September 04, 2017
Nordic Nanovector to Present at Pareto Securities’ 8th Annual HealthCare Conference
Media
August 25, 2017
Oncopeptides AB Interim Report April – June 2017
August 24, 2017
Targovax ASA: Second quarter and first half 2017 results
August 24, 2017
Wilson Therapeutics AB (publ) Interim Report January 1 – June 30, 2017
August 23, 2017
Nordic Nanovector ASA – Results for Second Quarter and First Half Year 2017
August 23, 2017
Targovax ASA: Abstracts accepted for poster presentation at the ESMO 2017 Congress
August 21, 2017
Altimmune Submits Investigational New Drug Application for NasoVAX in Preparation for Phase 2 Trial
August 17, 2017
Altimmune Announces $14.7 Million Series B Preferred Stock Offering
August 17, 2017
MIPS: INTERIM REPORT JANUARY – JUNE 2017
August 17, 2017
BONESUPPORT – Q2 2017 Interim Report – invitation to conference call and webcast